Recurrence of mogamulizumab-associated rash in patients with relapsed erythrodermic cutaneous T-cell lymphoma after retreatment with mogamulizumab

समान संसाधन

• Recurrence of mogamulizumab-associated rash in patients with relapsed erythrodermic cutaneous T-cell lymphoma after retreatment with mogamulizumab
  द्वारा: Emma R. McIntyre, BS, और अन्य
  प्रकाशित: (2025-10-01)
• Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
  द्वारा: Jordan Pilkington, और अन्य
  प्रकाशित: (2025-05-01)
• Sézary syndrome presenting as vitiligo-like leukoderma with response and repigmentation to mogamulizumab and extracorporeal photopheresis
  द्वारा: Elizabeth Anderson, MD, और अन्य
  प्रकाशित: (2026-02-01)
• Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas
  द्वारा: Caruso L, और अन्य
  प्रकाशित: (2022-11-01)
• Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study
  द्वारा: Antonio Giordano, और अन्य
  प्रकाशित: (2026-01-01)